Trium Capital’s scPharmaceuticals SCPH Stock Holding History

Trium Capital’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-32,710	Closed	-$185K	–	63
2025 Q3	$185K	Buy	+32,710	New	+$168K	0.07%	45

Trium Capital's SCPH Position: Q4 2025 in Review

Trium Capital sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 32,710 shares — an estimated $185K sold.

Trium Capital first reported a position in SCPH in Q3 2025 and held it in 1 quarter. The position peaked at $185K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Trium Capital reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Trium Capital sold 32,710 scPharmaceuticals shares in Q4 2025, an estimated $185K.
Trium Capital first reported a position in scPharmaceuticals in Q3 2025 and held it in 1 quarter.
Trium Capital's scPharmaceuticals position peaked at $185K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Trium Capital's 13F filing for Q4 2025, filed 22 Jan 2026.